NEW YORK, May 23 (GenomeWeb News) - Orchid BioSciences has paid $1.3 million to terminate a lease on a Plainsboro, NJ-based facility that the company had not used for over a year, according to a company filing with the US Securities and Exchange Commission.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.